SMTL ID : 6xtk.1

Y114C Transthyretin structure in complex with Tolcalpone

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

homo-tetramer

Ligands

4 x TCW: Tolcapone(Non-covalent)

TCW.1: 17 residues within 4Å: Chain A: K.6, L.8, A.99, A.100, L.101, S.108, T.109, T.110 Chain B: S.106 Chain C: K.6, L.8, T.97, A.99, L.101, S.108, T.110 Ligands: TCW.3 7 PLIP interactions: 4 interactions with chain C, 3 interactions with chain A Hydrophobic interactions: C:L.8, C:A.99, A:L.8, A:A.99 Hydrogen bonds: C:K.6, C:K.6, A:K.6 TCW.2: 18 residues within 4Å: Chain B: K.6, L.8, A.99, A.100, L.101, S.108, T.109, T.110, V.112 Chain D: K.6, L.8, T.97, A.99, L.101, S.108, T.110, V.112 Ligands: TCW.4 8 PLIP interactions: 5 interactions with chain B, 3 interactions with chain D Hydrophobic interactions: B:L.8, B:L.8, B:A.99, B:L.101, D:L.8, D:A.99 Hydrogen bonds: B:K.6, D:K.6 TCW.3: 17 residues within 4Å: Chain A: K.6, L.8, T.97, A.99, L.101, S.108, T.110 Chain C: K.6, L.8, A.99, A.100, L.101, S.108, T.109, T.110 Chain D: S.106 Ligands: TCW.1 7 PLIP interactions: 3 interactions with chain C, 4 interactions with chain A Hydrophobic interactions: C:L.8, C:A.99, A:L.8, A:A.99 Hydrogen bonds: C:K.6, A:K.6, A:K.6 TCW.4: 18 residues within 4Å: Chain B: K.6, L.8, T.97, A.99, L.101, S.108, T.110, V.112 Chain D: K.6, L.8, A.99, A.100, L.101, S.108, T.109, T.110, V.112 Ligands: TCW.2 8 PLIP interactions: 3 interactions with chain B, 5 interactions with chain D Hydrophobic interactions: B:L.8, B:A.99, D:L.8, D:L.8, D:A.99, D:L.101 Hydrogen bonds: B:K.6, D:K.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pinheiro, F. et al., Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis. Febs J. (2021)

Release Date

2020-05-13

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin